|
Catalog Number CON2006 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Cellulitis (1768); Seroma (2069)
|
Event Date 05/29/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Based on current information, relationship of this event cannot be determined.The internal investigation into lot # sp200194 included a review of the reported information, review of the complaint history records.There are no other complaints against this lot.Device history review has been requested, and is currently ongoing.Further follow up with the reporting healthcare professional will be conducted to obtain additional patient and event information.It was reported that the device will not be returned for analysis.
|
|
Event Description
|
Healthcare professional reported that patient developed heavy seroma out put around the strattice, which resulted in the removal of it."patient is doing well.".
|
|
Event Description
|
Healthcare professional reported patient was implanted with strattice for breast augmentation on (b)(6) 2020.Patient had bilateral jp drains removed on (b)(6) 2020, drains had 24-hour output of 15-20 cc each.Patient returned to the office on (b)(6) 2020 for follow up with complaints of progressive swelling in bilateral breasts.¿dr.(b)(6) exam showed tense, nontender breast with mild erythema." "patient developed heavy seroma output around the strattice".The decision was made at that time to return to the or to remove washout both breasts & remove strattice." ¿fluid was evacuated in surgery on (b)(6) 2020, sent for cultures, which were negative".Strattice was unincorporated at the time of explant.The explanted strattice were also sent for cultures, the results were not reported.Patient sent to infectious disease & received iv antibiotics.Ceftriaxone 2 g iv q 24 hours & daptomycin 320 mg iv q 24 hours on (b)(6) 2020 for 2 weeks.It was reported that the seroma lead to the patient having cellulitis.Patient is "currently off of antibiotics and doing well".
|
|
Manufacturer Narrative
|
Internal investigation into lot: sp200194 resulted in no remarkable findings including (b)(4) devices released to finished goods, (b)(4) have been distributed, (b)(4) have been reported as implanted.There has been one other related complaint (mfr#:1000306051-2020-00034), and 2 unrelated complaints reported to allergan against this lot: (pr 2158299, and pr 2158315).The lot was aseptically processed, terminally sterilized, and met qc release criteria.There were no processing deviations and 1 unrelated nonconformance (226752) related to the nature of this complaint.Based on the reported information, a relationship between the event and strattice cannot be determined.If additional information is reported, a follow up adverse event report will be submitted.No further actions are required as a nonconformance could not be confirmed.
|
|
Search Alerts/Recalls
|
|
|